Drug Shortage Report for RECOMBIVAX HB

Last updated on 2020-02-13 History
Report ID 23503
Drug Identification Number 02243676
Brand name RECOMBIVAX HB -(PRESERVATIVE FREE)
Common or Proper name (hepatitis B vaccine [recombinant])
Company Name MERCK CANADA INC
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 10MCG/1ML 1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-09-21
Actual start date 2017-09-21
Estimated end date 2021-03-01
Actual end date
Shortage status Actual shortage
Updated date 2020-02-13
Company comments Recombivax HB (Adult presentation): Anticipated end date March 2021 (tbc)
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-02-13 French Compare
v10 2020-02-13 English Compare
v9 2019-07-04 French Compare
v8 2019-07-04 English Compare
v7 2018-12-11 English Compare
v6 2018-05-30 English Compare
v5 2017-10-12 English Compare
v4 2017-09-26 French Compare
v3 2017-09-26 English Compare
v2 2017-09-26 English Compare
v1 2017-09-26 English Compare